Fig. 5From: Placebo-controlled randomized clinical trial of fish oil’s impact on fatigue, quality of life, and disease activity in Systemic Lupus ErythematosusBiomarkers. a Erythrocyte Sedimentation Rate (ESR) (p = 0.008), reduced in fish oil group b IL-13 (p = 0.033) elevated in fish oil group c IL-12 (p = 0.058), reduced in fish oil group. For all graphs, center bar represents median and upper and lower bars are the 25th and 75th percentiles. Data were analyzed with Mann–Whitney U testsBack to article page